Due Diligence for Life Sciences | Developing innovative strategies to successfully implement due diligence in mergers and acquisitions, and BD&L as a leverage to seize new opportunities

August 18-19, 2021 | Virtual Event

COVID-19 has hit the pharmaceutical industry in the mergers and acquisitions, IP, and due diligence areas within the life science industry. The challenges arise as pharma companies cannot successfully perform their due diligence or close deals virtually, which creates a barrier to deals while there is an increase in the sellers market. However, professionals say that COVID-19 and the production of vaccines grabbed new eyes to the life science space – which is likely to increase investor interest and awareness to the role it plays around the world. Even so, they believe that drug pricing conversations may begin again due to the new healthcare policies of the presidential administration where the US will mainly focus on biopharma investors.

Within new trends emerging the pressure to meet growth expectations are placing added emphasis and challenges with internal pipeline and development challenges are now focused on M&A activities for Life Science Companies. It is imperative for today’s organizations to develop robust M&A capabilities that address the challenges and opportunities of diversification; joint ventures, alliances, and licensing deals, and emerging markets.

SPEAKER HIGHLIGHTS

VIEW ALL SPEAKERS

WHO SHOULD ATTEND

Pharmaceutical, Biotechnology, and Medical Device professionals whose responsibilities include:

Secondary Market

Due Diligence
Business Development
Strategic Alliance/Alliance Management
Mergers and Acquisitions
Licensing
BD&L
Digital Partnerships
Digital Investments
Strategic Alliances/Partnerships Management
Intellectual Property and Patent Counsel
Search and Evaluation
Portfolio Management
General Counsel/Corporate Counsel
Legal and Regulatory Compliance
Legal / Intellectual Property
Portfolio / Life Cycle Management
Search and Evaluation
External Innovation
Clinical Operations
Regulatory Affairs
Compliance
Scientific Assessment
Transactions

Investment Banks
Private Equity Firms
Venture Capitalists
Data Room Providers
Due Diligence Consultants
Law Firms
Clinical Affairs and CRO Partners
Regulatory Affairs and Compliance Specialists

Top 5 Reasons to Attend

Reason 1: Maximize marketing efforts in order to increase facilities and IP due diligence
Reason 2: Evaluating new insights on reimbursements, rules and regulations and how it impacts deal-making while mitigating risks
Reason 3: Understanding the role and future of evolving trends such as digital therapeutics
Reason 4: Refine your growth strategies by implementing M&A integration, diligence, and deal sourcing
Reason 5: Evaluating the roadmap for integrating business development and the alliance management life-cycle

Silver Sponsor

Sponsorship Opportunities are Now Available!

If you are interested in sponsorship opportunities please send an email to Shelly Urish at shelly@momentumevents.com.

NETWORKING CAPABILITIES

✔ Virtual Matchmaking: Visit our virtual lobby and connect with fellow attendees using our platform’s matchmaking technology. You can chat, video, and even make a list of the people you want to meet and the knowledge you’re looking to gain through our bespoke 1:1 match-making services

✔ Roundtable Networking throughout the Summit will give you the chance to connect and meet in-depth your fellow attendees as well as our Sponsors and Speakers

✔ The platform we use allows us to make polls, QA, and chat during the sessions.

✔ Virtual Happy Hour: Grab a drink and bring it to your screen to cheers from afar while continuing to chat with and get to know your fellow conference participants.